We investigated the cases with Aeromonas bacteremia in terms of clinical and microbiological characteristics, underlying disease and mortality rates. Patients with positive blood cultures were included in this research. Aeromonas bacteremia was diagnosed as at least one positive blood culture for Aeromonas species. The bacteremia was defined as community origin if the onset was in the community or within 72 hours of hospital admission. The others were considered as nosocomial. All bacteria were defined as Aeromonas with conventional method. Species identification was verified by VITEK system. Antibiotic susceptibility tests were analyzed with the disc diffusion, E-test method or VITEK system. Thirty-three patients were diagnosed with bacteremia due to Aeromonas spp. Hematologic and solid tumors were the leading underlying conditions, followed by cirrhosis. Two patients (6%) had community-acquired infections. Aeromonas hydrophila was the most common isolated bacterium. The crude mortality rate was 36%. 12 patients died and 6 deaths and 4 deaths were detected in patients with bacteremia caused by A. hydrophila and Aeromonas sobria respectively. All strains were resistant to ampicillin and more than 90% of the strains were susceptible to trimethoprim-sulfamethoxazole, fluoroquinolone, third generation cephalosporins, and carbapenems. Aeromonas sp. is not a frequent cause of bacteremia however, it may lead to high mortality rates, especially in the immunocompromised hosts and patients with liver cirrhosis. Nosocomial Aeromonas bacteremia is not uncommon in these populations. Broad-spectrum cephalosporins, piperacillin-tazobactam, fluoroquinolones, and carbapenems remain as effective antimicrobial agents for therapy of Aeromonas bacteremia.
Edberg SC , Browne FA , Allen MJ . Issues for microbial regulation: Aeromonas as a model. Crit Rev Microbiol 2007; 33: 89–100.
J Glenn Morris AH 2018. Available from: www.uptodate.com, https://www.uptodate.com/contents/aeromonas-infections/contributors [Accessed 31 Aug 2019].
Janda JM , Abbott SL . Evolving concepts regarding the genus Aeromonas: an expanding panorama of species, disease presentations, and unanswered questions. Clin Infect Dis 1998; 27: 332–44.
Janda JM . Recent advances in the study of the taxonomy, pathogenicity, and infectious syndromes associated with the genus Aeromonas. Clin Microbiol Rev 1991; 4: 397–410.
n.d. Available from: www.cdc.gov, https://www.cdc.gov/nhsn/pdfs/pscmanual/4psc_clabscurrent.pdf [Accessed 11 Oct 2020].
French GL , Cheng AF , Duthie R , Cockram CS . Septicaemia in Hong Kong. J Antimicrob Chemother 1990; 25: 115–25.
Bahçe YG , Toyran A , Aksoy A . Direct identification and determination of antimicrobial susceptibility of Gram-negative bacilli using the PhoenixTM FX system in blood cultures flagging positive. Mikrobiyol Bul 2019; 53: 119-133.
Kitagawa H , Ohge H , Yu L , Kayama S , Hara T , Kashiyama S , Kajihara T , Hisatsune J , Sueda T , Sugai M . Aeromonas dhakensis is not a rare cause of Aeromonas bacteremia in Hiroshima, Japan. J Infect Chemother 2020; 26: 316-320.
Ko WC , Chuang YC . Aeromonas bacteremia: review of 59 episodes. Clin Infect Dis 1995; 20: 1298–304.
Ko WC , Lee HC , Chuang YC , Liu CC , Wu JJ . Clinical features and therapeutic implications of 104 episodes of monomicrobial Aeromonas bacteraemia. J Infect 2000; 40: 267–73.
Lau SM , Peng MY , Chang FY . Outcomes of Aeromonas bacteremia in patients with different types of underlying disease. J Microbiol Immunol Infect 2000; 33: 241–7.
Llopis F , Grau I , Tubau F , Cisnal M , Pallares R . Epidemiological and clinical characteristics of bacteraemia caused by Aeromonas spp. as compared compared with Escherichia coli and Pseudomonas aeruginosa. Scand J Infect Dis 2004; 36: 335–41.
Tsai MS , Kuo CY , Wang MC , Wu HC , Chien CC , Liu JW . Clinical features and risk factors for mortality in Aeromonas bacteremic adults with hematologic malignancies. J Microbiol Immunol Infect 2006; 39: 150–4.
Lakatos B , Szabó H , Csordás K , Tatai G , Nikolova R , Csomor J , Reményi P , Masszi T , Vályi-Nagy I , Sinkó J . Epidemiology of early infections after autologous hematopoietic stem cell transplantation. Analysis of data from 699 patients treated in a Hungarian centre. Orv Hetil 2020; 161: 103-109.
Wu CJ , Wu JJ , Yan JJ , Lee HC , Lee NY , Chang CM , et al. Clinical significance and distribution of putative virulence markers of 116 consecutive clinical Aeromonas isolates in southern Taiwan. J Infect 2007; 54: 151–8.
Duthie R , Ling TW , Cheng AFB , French GL . Aeromonas septicaemia in Hong Kong species distribution and associated disease. J Infect 1995; 30: 241–4.
Harris RL , Fainstein V , Elting L , Hopfer RL , Bodey GP . Bacteremia caused by Aeromonas species in hospitalized cancer patients. Rev Infect Dis 1985; 7: 314–20.
Funada H , Matsuda T . Aeromonas bacteremia in patients with hematologic diseases. Intern Med 1997; 36: 171–4.
Wang JH , Wang CY , Chi CY , Ho MW , Ho CM , Lin PC . Clinical presentations, prognostic factors, and mortality in patients with Aeromonas sobria complex bacteremia in a teaching hospital: a 5-year experience. J Microbiol Immunol Infect 2009; 42: 510–5.
Hofer E , Reis CMF dos , Theophilo GND , Cavalcanti VO , Lima NV de , Henriques M de FC de M . [Aeromonas associated with an acute diarrhea outbreak in São Bento do Una, Pernambuco]. Revista Da Sociedade Brasileira de Medicina Trop 2006; 239: 217–20.
Janda JM , Abbott SL . The genus Aeromonas: taxonomy, pathogenicity, and infection. Clin Microbiol Rev 2010; 23: 35–73.
Janda JM , Guthertz LS , Kokka RP , Shimada T . Aeromonas species in septicemia: laboratory characteristics and clinical observations. Clin Infect Dis 1994; 19: 77–83.
Moura Q , Fernandes MR , Cerdeira L , Santos ACM , de Souza TA , Ienne S , Pignatari ACC , Gales AC , Silva RM , Lincopan N . Draft genome sequence of a multidrug resistant Aeromonas hydrophila ST508 strain carrying rmtD and bla(CTX-M-131) isolated from a bloodstream infection. J Glob Antimicrob Resist 2017; 10: 289-290.
Sherlock CH , Burdge DR , Smith JA . Does Aeromonas hydrophila preferentially colonize the bowels of patients with hematologic malignancies? Diagn Microbiol Infect Dis 1987; 7: 63–8.
Nagata K , Takeshima Y , Tomii K , Imai Y . Fulminant fatal bacteremic pneumonia due to Aeromonas hydrophila in a non immunocompromised woman. Intern Med 2011; 50: 63–5.
Mukhopadhyay C , Bhargava A , Ayyagari A . Aeromonas hydrophila and aspiration pneumonia: a diverse presentation. Yonsei Med J 2003; 44: 1087–90.
Murphy OM , Gray J , Pedler SJ . Non-enteritic Aeromonas infections in hospitalized patients. J Hosp Infect 1995; 31: 55–60.
Kimura M , Araoka H , Yoneyama A . Aeromonas caviae is the most frequent pathogen amongst cases of Aeromonas bacteremia in Japan. Scand J Infect Dis 2013; 45: 304–9.
Patel KM , Svestka M , Sinkin J , Ruff P . Ciprofloxacin-resistant Aeromonas hydrophila infection following leech therapy: a case report and review of the literature. J Plast Reconstr Aesthet Surg 2013; 66: 20-2.